The Importance Of Immunoprophylaxis For Tuberculosis (BCG Vaccination)

Bayramgul Sadikovna Jumamuratova

doi:10.37547/tajmspr/volume03issue10-04

Abstract

Vaccination is a costly activity, as it involves coverage of a wide population. Methods to assess the effectiveness of immunoprophylaxis and the quality of preventive (anti-epidemic) measures are discussed in this context.

Highlights

Throughout its 215-year history, vaccine prophylaxis has proven to be extremely effective in preserving human life and reducing morbidity and mortality
The organisation predicts that if this type of prevention is introduced throughout the republic and if 85% of those covered complete the course of medication, the incidence of tuberculosis will fall by 8% a year in the future
The BCG vaccination is needed to prevent tuberculosis in children. It does not protect against infection by the TB pathogen, but it protects against the transition from latent infection to manifest disease and almost 100 % of children against serious forms of TB - TB meningitis, TB in the bones and joints and serious forms of TB in the lungs. It is the use of BCG vaccine that has enabled a significant reduction in the incidence of TB in children in general, and in particular, for many years despite the difficult social situation, we have not seen any cases of TB meningitis in vaccinated children

Summary

INTRODUCTION

Throughout its 215-year history, vaccine prophylaxis has proven to be extremely effective in preserving human life and reducing morbidity and mortality. According to WHO experts, vaccination and clean drinking water are the only proven measures to have a real impact on public health. Vaccination is the most effective and cost-effective preventive measure known in modern medicine). In its first years of use, the vaccine was used to induce artificial immunity in newborns by injecting it with the mother's expressed milk. The cutaneous method of vaccination was developed and introduced. The vaccine is administered intradermally (c/k) to the forearm in the maternity hospital. The vaccination is repeated at the age of 6-7 years and, if necessary, at the age of 14-15 years

MATERIALS AND METHODS

Findings

CONCLUSIONS